Investor Resources
Crinetics Pharmaceuticals Appoints Stephanie Okey to Board of Directors
“Stephanie’s extensive experience with the regulatory approval process, launch and commercialization of rare and orphan disease products makes her a valuable addition to our board,” said
Ms. Okey has extensive leadership and management experience in the life sciences industry and has contributed to the commercialization of a number of rare disease products. Her professional experience includes roles in field sales and marketing at
“It is exciting to be part of a company that is truly patient-focused,” said Ms. Okey. “I look forward to working alongside the Crinetics leadership team and the rest of the board as we continue to make progress in bringing important new therapeutics to patients with rare endocrine diseases and endocrine tumors.”
About
Contacts:
Chief Financial Officer
IR@crinetics.com
(858) 450-6464
Westwicke Partners
robert.uhl@westwicke.com
(858) 356-5932
Source: Crinetics Pharmaceuticals, Inc.